The US state of Connecticut has unanimously approved legislation whichprohibits school officials, including teachers and counselors, from recommending that a child be prescribed psychiatric drugs.
Connecticut thus becomes the first US state law to act against what is increasingly being seen as overuse of drugs such as Novartis' Ritalin (methylphenidate) and Shire Pharmaceuticals' Adderall (mixed amphetamine salts) to treat attention deficit hyperactivity disorder in children. IMS Health reports that most of the 35% rise in prescribing of these drugs during 1996-1999 was for boys aged under 12, notes the Associated Press.
Under the Connecticut law, a school official can still recommend that a child with behavioral or learning problems should be examined by a physician, but it aims to ensure that the first mention of drug treatment should come from the doctor.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze